Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy – ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2020-01-30

AUTHORS

Alice Boilève, Aline Maillard, Mathilde Wagner, Clarisse Dromain, Christophe Laurent, Eric Dupont Bierre, Samuel Le Sourd, Franck Audemar, Ayhan Ulusakarya, Veronique Guerin-Meyer, Denis Smisth, Veronica Pezzella, Thierry De Baere, Diane Goere, Maximiliano Gelli, Julien Taieb, Valérie Boige

ABSTRACT

BackgroundApproximately 40% of colorectal cancer patients will develop colorectal liver metastases (CRLM). The most effective approach to increase long-term survival is CRLM complete resection. Unfortunately, only 10–15% of CRLM are initially considered resectable. The objective response rates (ORR) after current first-line systemic chemotherapy (sys-CT) regimens range from 40 to 80% and complete resection rates (CRR) range from 25 to 50% in patients with initially unresectable CRLM. When CRLM patients are not amenable to complete resection after induction of sys-CT, ORRs obtained with second-line sys-CT are much lower (between 10 and 30%) and consequently CRRs are also low (< 10%). Hepatic arterial infusion (HAI) oxaliplatin may represent a salvage therapy in patients with CRLM unresectable after one or more sys-CT regimens with ORRs and CRRs up to 60 and 30%, respectively. This study is designed to evaluate the efficacy of an intensification strategy based on HAI oxaliplatin combined with sys-CT as a salvage treatment in patients with CRLM unresectable after at least 2 months of first-line induction sys-CT.Objectives and endpoints of the phase II studyOur main objective is to investigate the efficacy, in term of CRR (R0-R1), of treatment intensification in patients with liver-only CRLM not amenable to curative-intent resection (and/or ablation) after at least 2 months of induction sys-CT. Patients will receive either HAI oxaliplatin plus systemic FOLFIRI plus targeted therapy (i.e. anti-EGFR antibody or bevacizumab) or conventional sys-CT plus targeted therapy (i.e. anti-EGFR or antiangiogenic antibody). Secondary objectives are to compare: progression-free survival, overall survival, objective response rate, depth of response, feasibility of delivering HAI oxaliplatin including HAI catheter-related complications, and toxicity (NCI-CTCAE v4.0).MethodsThis study is a multicenter, randomized, comparative phase II trial (power, 80%; two-sided alpha-risk, 5%). Patients will be randomly assigned in a 1:1 ratio to receive HAI oxaliplatin combined with systemic FOLFIRI plus targeted therapy (experimental arm) or the best sys-CT plus targeted therapy on the basis of their first-line prior sys-CT history and current guidelines (control arm). One hundred forty patients are required to account for non-evaluable patients.Trial registrationClinicalTrials.gov, (NCT03164655). Trial registration date: 11th May 2017. More... »

PAGES

74

Journal

TITLE

BMC Cancer

ISSUE

1

VOLUME

20

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12885-020-6571-7

DOI

http://dx.doi.org/10.1186/s12885-020-6571-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1124438152

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/32000724


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clinical Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colorectal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatic Artery", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Induction Chemotherapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infusions, Intra-Arterial", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif Cedex, France", 
          "id": "http://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Department of Medical Oncology, Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif Cedex, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Boil\u00e8ve", 
        "givenName": "Alice", 
        "id": "sg:person.01202757101.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202757101.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre for Research in Epidemiology and Population Health (team 2), INSERM U1018, Paris-Saclay University, Villejuif, France", 
          "id": "http://www.grid.ac/institutes/grid.463845.8", 
          "name": [
            "Department of statistics and epidemiology, Villejuif, France", 
            "Centre for Research in Epidemiology and Population Health (team 2), INSERM U1018, Paris-Saclay University, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maillard", 
        "givenName": "Aline", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of radiology, CHU Piti\u00e9 Salp\u00e9tri\u00e8re, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.411439.a", 
          "name": [
            "Department of radiology, CHU Piti\u00e9 Salp\u00e9tri\u00e8re, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wagner", 
        "givenName": "Mathilde", 
        "id": "sg:person.01034526661.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034526661.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of radiology, Centre Hospitalier et Universitaire Vaudois, Lausanne, Switzerland", 
          "id": "http://www.grid.ac/institutes/grid.8515.9", 
          "name": [
            "Department of radiology, Centre Hospitalier et Universitaire Vaudois, Lausanne, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dromain", 
        "givenName": "Clarisse", 
        "id": "sg:person.0771070144.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771070144.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of hepatogastroenterology, H\u00f4pital Haut Lev\u00eaque, Pessac, France", 
          "id": "http://www.grid.ac/institutes/grid.42399.35", 
          "name": [
            "Department of hepatogastroenterology, H\u00f4pital Haut Lev\u00eaque, Pessac, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Laurent", 
        "givenName": "Christophe", 
        "id": "sg:person.01275745276.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01275745276.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of digestive surgery, CHP Saint Gr\u00e9goire, Saint-Gr\u00e9goire, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of digestive surgery, CHP Saint Gr\u00e9goire, Saint-Gr\u00e9goire, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dupont Bierre", 
        "givenName": "Eric", 
        "id": "sg:person.01020424060.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01020424060.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of medical oncology, Centre Eug\u00e8ne-Marquis, Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.417988.b", 
          "name": [
            "Department of medical oncology, Centre Eug\u00e8ne-Marquis, Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Le Sourd", 
        "givenName": "Samuel", 
        "id": "sg:person.01110132160.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110132160.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of hepatogastroenterology, Centre hospitalier C\u00f4te Basque, Bayonne, France", 
          "id": "http://www.grid.ac/institutes/grid.418076.c", 
          "name": [
            "Department of hepatogastroenterology, Centre hospitalier C\u00f4te Basque, Bayonne, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Audemar", 
        "givenName": "Franck", 
        "id": "sg:person.07565600260.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07565600260.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of medical oncology, H\u00f4pital Paul Brousse, Villejuif, France", 
          "id": "http://www.grid.ac/institutes/grid.413133.7", 
          "name": [
            "Department of medical oncology, H\u00f4pital Paul Brousse, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ulusakarya", 
        "givenName": "Ayhan", 
        "id": "sg:person.0576763251.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0576763251.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of medical oncology, Institut de Cancerologie de l\u2019Ouest, Angers, France", 
          "id": "http://www.grid.ac/institutes/grid.418191.4", 
          "name": [
            "Department of medical oncology, Institut de Cancerologie de l\u2019Ouest, Angers, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Guerin-Meyer", 
        "givenName": "Veronique", 
        "id": "sg:person.01174560674.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174560674.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of hepatogastroenterology, H\u00f4pital Haut Lev\u00eaque, Pessac, France", 
          "id": "http://www.grid.ac/institutes/grid.42399.35", 
          "name": [
            "Department of hepatogastroenterology, H\u00f4pital Haut Lev\u00eaque, Pessac, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Smisth", 
        "givenName": "Denis", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "R&D Unicancer, Paris, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "R&D Unicancer, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pezzella", 
        "givenName": "Veronica", 
        "id": "sg:person.07474010031.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07474010031.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of interventional radiology, Gustave Roussy, Villejuif, France", 
          "id": "http://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Department of interventional radiology, Gustave Roussy, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "De Baere", 
        "givenName": "Thierry", 
        "id": "sg:person.01347655027.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01347655027.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgical Oncology, H\u00f4pital Saint Louis, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.413328.f", 
          "name": [
            "Department of Surgical Oncology, H\u00f4pital Saint Louis, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goere", 
        "givenName": "Diane", 
        "id": "sg:person.01252375415.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252375415.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgical Oncology, Gustave Roussy, Villejuif, France", 
          "id": "http://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Department of Surgical Oncology, Gustave Roussy, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gelli", 
        "givenName": "Maximiliano", 
        "id": "sg:person.0734163345.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0734163345.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of digestive oncology, H\u00f4pital Europ\u00e9en Georges-Pompidou, Sorbonne Paris Cite/Paris Descartes University, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.414093.b", 
          "name": [
            "Department of digestive oncology, H\u00f4pital Europ\u00e9en Georges-Pompidou, Sorbonne Paris Cite/Paris Descartes University, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Taieb", 
        "givenName": "Julien", 
        "id": "sg:person.01203564254.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203564254.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif Cedex, France", 
          "id": "http://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Department of Medical Oncology, Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif Cedex, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Boige", 
        "givenName": "Val\u00e9rie", 
        "id": "sg:person.01243532122.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01243532122.09"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1245/s10434-007-9581-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021729392", 
          "https://doi.org/10.1245/s10434-007-9581-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00270-010-9996-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033215339", 
          "https://doi.org/10.1007/s00270-010-9996-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6603033", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051210499", 
          "https://doi.org/10.1038/sj.bjc.6603033"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2020-01-30", 
    "datePublishedReg": "2020-01-30", 
    "description": "BackgroundApproximately 40% of colorectal cancer patients will develop colorectal liver metastases (CRLM). The most effective approach to increase long-term survival is CRLM complete resection. Unfortunately, only 10\u201315% of CRLM are initially considered resectable. The objective response rates (ORR) after current first-line systemic chemotherapy (sys-CT) regimens range from 40 to 80% and complete resection rates (CRR) range from 25 to 50% in patients with initially unresectable CRLM. When CRLM patients are not amenable to complete resection after induction of sys-CT, ORRs obtained with second-line sys-CT are much lower (between 10 and 30%) and consequently CRRs are also low (<\u200910%). Hepatic arterial infusion (HAI) oxaliplatin may represent a salvage therapy in patients with CRLM unresectable after one or more sys-CT regimens with ORRs and CRRs up to 60 and 30%, respectively. This study is designed to evaluate the efficacy of an intensification strategy based on HAI oxaliplatin combined with sys-CT as a salvage treatment in patients with CRLM unresectable after at least 2 months of first-line induction sys-CT.Objectives and endpoints of the phase II studyOur main objective is to investigate the efficacy, in term of CRR (R0-R1), of treatment intensification in patients with liver-only CRLM not amenable to curative-intent resection (and/or ablation) after at least 2 months of induction sys-CT. Patients will receive either HAI oxaliplatin plus systemic FOLFIRI plus targeted therapy (i.e. anti-EGFR antibody or bevacizumab) or conventional sys-CT plus targeted therapy (i.e. anti-EGFR or antiangiogenic antibody). Secondary objectives are to compare: progression-free survival, overall survival, objective response rate, depth of response, feasibility of delivering HAI oxaliplatin including HAI catheter-related complications, and toxicity (NCI-CTCAE v4.0).MethodsThis study is a multicenter, randomized, comparative phase II trial (power, 80%; two-sided alpha-risk, 5%). Patients will be randomly assigned in a 1:1 ratio to receive HAI oxaliplatin combined with systemic FOLFIRI plus targeted therapy (experimental arm) or the best sys-CT plus targeted therapy on the basis of their first-line prior sys-CT history and current guidelines (control arm). One hundred forty patients are required to account for non-evaluable patients.Trial registrationClinicalTrials.gov, (NCT03164655). Trial registration date: 11th May 2017.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s12885-020-6571-7", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024632", 
        "issn": [
          "1471-2407"
        ], 
        "name": "BMC Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "20"
      }
    ], 
    "keywords": [
      "colorectal liver metastases", 
      "objective response rate", 
      "complete resection rate", 
      "HAI oxaliplatin", 
      "treatment intensification", 
      "response rate", 
      "first-line systemic chemotherapy", 
      "hepatic arterial infusion (HAI) oxaliplatin", 
      "hepatic arterial infusion chemotherapy", 
      "unresectable colorectal liver metastases", 
      "randomized phase II study", 
      "non-evaluable patients", 
      "curative-intent resection", 
      "arterial infusion chemotherapy", 
      "phase II study", 
      "progression-free survival", 
      "catheter-related complications", 
      "phase II trial", 
      "colorectal cancer patients", 
      "depth of response", 
      "comparative phase II trial", 
      "systemic induction chemotherapy", 
      "long-term survival", 
      "salvage therapy", 
      "induction chemotherapy", 
      "systemic chemotherapy", 
      "resection rate", 
      "CRLM patients", 
      "salvage treatment", 
      "II trial", 
      "infusion chemotherapy", 
      "liver metastases", 
      "overall survival", 
      "colorectal metastases", 
      "II study", 
      "complete resection", 
      "cancer patients", 
      "study protocol", 
      "current guidelines", 
      "MethodsThis study", 
      "patients", 
      "oxaliplatin", 
      "therapy", 
      "secondary objective", 
      "resection", 
      "chemotherapy", 
      "FOLFIRI", 
      "metastasis", 
      "survival", 
      "liver", 
      "months", 
      "efficacy", 
      "multicenter", 
      "complications", 
      "trials", 
      "endpoint", 
      "CT", 
      "study", 
      "rate", 
      "treatment", 
      "toxicity", 
      "induction", 
      "objective", 
      "guidelines", 
      "response", 
      "history", 
      "effective approach", 
      "intensification strategies", 
      "protocol", 
      "strategies", 
      "feasibility", 
      "ratio", 
      "main objective", 
      "basis", 
      "intensification", 
      "approach", 
      "terms", 
      "depth"
    ], 
    "name": "Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy \u2013 a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol", 
    "pagination": "74", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1124438152"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12885-020-6571-7"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "32000724"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12885-020-6571-7", 
      "https://app.dimensions.ai/details/publication/pub.1124438152"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:37", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_870.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s12885-020-6571-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12885-020-6571-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12885-020-6571-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12885-020-6571-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12885-020-6571-7'


 

This table displays all metadata directly associated to this object as RDF triples.

345 TRIPLES      22 PREDICATES      118 URIs      106 LITERALS      17 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12885-020-6571-7 schema:about N08011255d7fc4d3bbcd36d5b2cc7fdd5
2 N1c0fe148dfd44ed38212da4345e7116e
3 N317987827e85444fb1944d8d78883c1c
4 N847da549dc904539b56fd958d920bd27
5 N96d3842a3c524cf8a4cf076bfbaa8b3b
6 Nb4575bf37ee84be796a5bd72815a196d
7 Nc139b664f04146eeb1415ffed74c1b35
8 Nd222f44b1cbe4ccfaa6659f7bf04614b
9 Nd3d7a438b68e4060a654ee60ab5d43e7
10 Nf171a49b328046db855e877dff8fcd84
11 anzsrc-for:11
12 anzsrc-for:1103
13 anzsrc-for:1112
14 schema:author N078103f5f61f40308c3293352eee6060
15 schema:citation sg:pub.10.1007/s00270-010-9996-6
16 sg:pub.10.1038/sj.bjc.6603033
17 sg:pub.10.1245/s10434-007-9581-7
18 schema:datePublished 2020-01-30
19 schema:datePublishedReg 2020-01-30
20 schema:description BackgroundApproximately 40% of colorectal cancer patients will develop colorectal liver metastases (CRLM). The most effective approach to increase long-term survival is CRLM complete resection. Unfortunately, only 10–15% of CRLM are initially considered resectable. The objective response rates (ORR) after current first-line systemic chemotherapy (sys-CT) regimens range from 40 to 80% and complete resection rates (CRR) range from 25 to 50% in patients with initially unresectable CRLM. When CRLM patients are not amenable to complete resection after induction of sys-CT, ORRs obtained with second-line sys-CT are much lower (between 10 and 30%) and consequently CRRs are also low (< 10%). Hepatic arterial infusion (HAI) oxaliplatin may represent a salvage therapy in patients with CRLM unresectable after one or more sys-CT regimens with ORRs and CRRs up to 60 and 30%, respectively. This study is designed to evaluate the efficacy of an intensification strategy based on HAI oxaliplatin combined with sys-CT as a salvage treatment in patients with CRLM unresectable after at least 2 months of first-line induction sys-CT.Objectives and endpoints of the phase II studyOur main objective is to investigate the efficacy, in term of CRR (R0-R1), of treatment intensification in patients with liver-only CRLM not amenable to curative-intent resection (and/or ablation) after at least 2 months of induction sys-CT. Patients will receive either HAI oxaliplatin plus systemic FOLFIRI plus targeted therapy (i.e. anti-EGFR antibody or bevacizumab) or conventional sys-CT plus targeted therapy (i.e. anti-EGFR or antiangiogenic antibody). Secondary objectives are to compare: progression-free survival, overall survival, objective response rate, depth of response, feasibility of delivering HAI oxaliplatin including HAI catheter-related complications, and toxicity (NCI-CTCAE v4.0).MethodsThis study is a multicenter, randomized, comparative phase II trial (power, 80%; two-sided alpha-risk, 5%). Patients will be randomly assigned in a 1:1 ratio to receive HAI oxaliplatin combined with systemic FOLFIRI plus targeted therapy (experimental arm) or the best sys-CT plus targeted therapy on the basis of their first-line prior sys-CT history and current guidelines (control arm). One hundred forty patients are required to account for non-evaluable patients.Trial registrationClinicalTrials.gov, (NCT03164655). Trial registration date: 11th May 2017.
21 schema:genre article
22 schema:inLanguage en
23 schema:isAccessibleForFree true
24 schema:isPartOf N253827b84ee141d195cfbf793d810930
25 N9006dbdad73b46779bc5741d8d7371b0
26 sg:journal.1024632
27 schema:keywords CRLM patients
28 CT
29 FOLFIRI
30 HAI oxaliplatin
31 II study
32 II trial
33 MethodsThis study
34 approach
35 arterial infusion chemotherapy
36 basis
37 cancer patients
38 catheter-related complications
39 chemotherapy
40 colorectal cancer patients
41 colorectal liver metastases
42 colorectal metastases
43 comparative phase II trial
44 complete resection
45 complete resection rate
46 complications
47 curative-intent resection
48 current guidelines
49 depth
50 depth of response
51 effective approach
52 efficacy
53 endpoint
54 feasibility
55 first-line systemic chemotherapy
56 guidelines
57 hepatic arterial infusion (HAI) oxaliplatin
58 hepatic arterial infusion chemotherapy
59 history
60 induction
61 induction chemotherapy
62 infusion chemotherapy
63 intensification
64 intensification strategies
65 liver
66 liver metastases
67 long-term survival
68 main objective
69 metastasis
70 months
71 multicenter
72 non-evaluable patients
73 objective
74 objective response rate
75 overall survival
76 oxaliplatin
77 patients
78 phase II study
79 phase II trial
80 progression-free survival
81 protocol
82 randomized phase II study
83 rate
84 ratio
85 resection
86 resection rate
87 response
88 response rate
89 salvage therapy
90 salvage treatment
91 secondary objective
92 strategies
93 study
94 study protocol
95 survival
96 systemic chemotherapy
97 systemic induction chemotherapy
98 terms
99 therapy
100 toxicity
101 treatment
102 treatment intensification
103 trials
104 unresectable colorectal liver metastases
105 schema:name Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy – a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol
106 schema:pagination 74
107 schema:productId Na3664035f691436c960a32ef8b4dfac4
108 Nba1e48cdbd22446684048b128c6c2bf2
109 Nf7452fe74eb94c1799e365a79680d4f5
110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1124438152
111 https://doi.org/10.1186/s12885-020-6571-7
112 schema:sdDatePublished 2022-05-20T07:37
113 schema:sdLicense https://scigraph.springernature.com/explorer/license/
114 schema:sdPublisher N3d00d16aff8c4e33ad9937adcf4fb4ae
115 schema:url https://doi.org/10.1186/s12885-020-6571-7
116 sgo:license sg:explorer/license/
117 sgo:sdDataset articles
118 rdf:type schema:ScholarlyArticle
119 N078103f5f61f40308c3293352eee6060 rdf:first sg:person.01202757101.13
120 rdf:rest N9749a8c4340b4ce89c3e2f412617681b
121 N08011255d7fc4d3bbcd36d5b2cc7fdd5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Infusions, Intra-Arterial
123 rdf:type schema:DefinedTerm
124 N1c0fe148dfd44ed38212da4345e7116e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Liver Neoplasms
126 rdf:type schema:DefinedTerm
127 N253827b84ee141d195cfbf793d810930 schema:issueNumber 1
128 rdf:type schema:PublicationIssue
129 N2879a8d1daa1440988e7c582ae7de795 rdf:first sg:person.0734163345.11
130 rdf:rest Ndefb2c4b58be4ec999cb9fb313755c71
131 N317987827e85444fb1944d8d78883c1c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Clinical Protocols
133 rdf:type schema:DefinedTerm
134 N3d00d16aff8c4e33ad9937adcf4fb4ae schema:name Springer Nature - SN SciGraph project
135 rdf:type schema:Organization
136 N3ecb8502333d4c7f813ee0cae06c1211 rdf:first sg:person.01243532122.09
137 rdf:rest rdf:nil
138 N5c84f89647804970b53890473ead8307 rdf:first sg:person.01174560674.11
139 rdf:rest Nba3ba55180404135bb1192e491eb73b2
140 N5ff917a270a54664bad20f0af6152d1b rdf:first sg:person.01110132160.38
141 rdf:rest Nae3292c35b6f4df9b8d893fa32c01ad3
142 N670a767590d742b1b18798a56be50eee rdf:first sg:person.0576763251.36
143 rdf:rest N5c84f89647804970b53890473ead8307
144 N6e00ea04fbdf4eb1880eda0a7c7b5964 rdf:first sg:person.0771070144.24
145 rdf:rest Nb096102743584fb182a83a0dda636016
146 N74fb602328a544b48234e097b5f5c01d rdf:first sg:person.01347655027.14
147 rdf:rest Nd630de71299340d4825c33be18c67f03
148 N847da549dc904539b56fd958d920bd27 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Antineoplastic Combined Chemotherapy Protocols
150 rdf:type schema:DefinedTerm
151 N849a075a87574fc19035debde1bc448b rdf:first sg:person.07474010031.50
152 rdf:rest N74fb602328a544b48234e097b5f5c01d
153 N9006dbdad73b46779bc5741d8d7371b0 schema:volumeNumber 20
154 rdf:type schema:PublicationVolume
155 N96d3842a3c524cf8a4cf076bfbaa8b3b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Hepatic Artery
157 rdf:type schema:DefinedTerm
158 N9749a8c4340b4ce89c3e2f412617681b rdf:first Nd6f5cdcca26348f9994fab5a3d222898
159 rdf:rest Na9cb33df35974843a9aa9c48b0772b9c
160 N9ffac60ebe364af598420aa5dff8f640 schema:affiliation grid-institutes:grid.42399.35
161 schema:familyName Smisth
162 schema:givenName Denis
163 rdf:type schema:Person
164 Na3664035f691436c960a32ef8b4dfac4 schema:name pubmed_id
165 schema:value 32000724
166 rdf:type schema:PropertyValue
167 Na9cb33df35974843a9aa9c48b0772b9c rdf:first sg:person.01034526661.15
168 rdf:rest N6e00ea04fbdf4eb1880eda0a7c7b5964
169 Nae3292c35b6f4df9b8d893fa32c01ad3 rdf:first sg:person.07565600260.23
170 rdf:rest N670a767590d742b1b18798a56be50eee
171 Nb096102743584fb182a83a0dda636016 rdf:first sg:person.01275745276.40
172 rdf:rest Ncc49afdae6fd497aafb182a1f3607d69
173 Nb4575bf37ee84be796a5bd72815a196d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Male
175 rdf:type schema:DefinedTerm
176 Nba1e48cdbd22446684048b128c6c2bf2 schema:name doi
177 schema:value 10.1186/s12885-020-6571-7
178 rdf:type schema:PropertyValue
179 Nba3ba55180404135bb1192e491eb73b2 rdf:first N9ffac60ebe364af598420aa5dff8f640
180 rdf:rest N849a075a87574fc19035debde1bc448b
181 Nc139b664f04146eeb1415ffed74c1b35 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Female
183 rdf:type schema:DefinedTerm
184 Ncc49afdae6fd497aafb182a1f3607d69 rdf:first sg:person.01020424060.75
185 rdf:rest N5ff917a270a54664bad20f0af6152d1b
186 Nd222f44b1cbe4ccfaa6659f7bf04614b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Colorectal Neoplasms
188 rdf:type schema:DefinedTerm
189 Nd3d7a438b68e4060a654ee60ab5d43e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Induction Chemotherapy
191 rdf:type schema:DefinedTerm
192 Nd630de71299340d4825c33be18c67f03 rdf:first sg:person.01252375415.47
193 rdf:rest N2879a8d1daa1440988e7c582ae7de795
194 Nd6f5cdcca26348f9994fab5a3d222898 schema:affiliation grid-institutes:grid.463845.8
195 schema:familyName Maillard
196 schema:givenName Aline
197 rdf:type schema:Person
198 Ndefb2c4b58be4ec999cb9fb313755c71 rdf:first sg:person.01203564254.60
199 rdf:rest N3ecb8502333d4c7f813ee0cae06c1211
200 Nf171a49b328046db855e877dff8fcd84 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
201 schema:name Humans
202 rdf:type schema:DefinedTerm
203 Nf7452fe74eb94c1799e365a79680d4f5 schema:name dimensions_id
204 schema:value pub.1124438152
205 rdf:type schema:PropertyValue
206 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
207 schema:name Medical and Health Sciences
208 rdf:type schema:DefinedTerm
209 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
210 schema:name Clinical Sciences
211 rdf:type schema:DefinedTerm
212 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
213 schema:name Oncology and Carcinogenesis
214 rdf:type schema:DefinedTerm
215 sg:journal.1024632 schema:issn 1471-2407
216 schema:name BMC Cancer
217 schema:publisher Springer Nature
218 rdf:type schema:Periodical
219 sg:person.01020424060.75 schema:affiliation grid-institutes:None
220 schema:familyName Dupont Bierre
221 schema:givenName Eric
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01020424060.75
223 rdf:type schema:Person
224 sg:person.01034526661.15 schema:affiliation grid-institutes:grid.411439.a
225 schema:familyName Wagner
226 schema:givenName Mathilde
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034526661.15
228 rdf:type schema:Person
229 sg:person.01110132160.38 schema:affiliation grid-institutes:grid.417988.b
230 schema:familyName Le Sourd
231 schema:givenName Samuel
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110132160.38
233 rdf:type schema:Person
234 sg:person.01174560674.11 schema:affiliation grid-institutes:grid.418191.4
235 schema:familyName Guerin-Meyer
236 schema:givenName Veronique
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174560674.11
238 rdf:type schema:Person
239 sg:person.01202757101.13 schema:affiliation grid-institutes:grid.14925.3b
240 schema:familyName Boilève
241 schema:givenName Alice
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202757101.13
243 rdf:type schema:Person
244 sg:person.01203564254.60 schema:affiliation grid-institutes:grid.414093.b
245 schema:familyName Taieb
246 schema:givenName Julien
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203564254.60
248 rdf:type schema:Person
249 sg:person.01243532122.09 schema:affiliation grid-institutes:grid.14925.3b
250 schema:familyName Boige
251 schema:givenName Valérie
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01243532122.09
253 rdf:type schema:Person
254 sg:person.01252375415.47 schema:affiliation grid-institutes:grid.413328.f
255 schema:familyName Goere
256 schema:givenName Diane
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252375415.47
258 rdf:type schema:Person
259 sg:person.01275745276.40 schema:affiliation grid-institutes:grid.42399.35
260 schema:familyName Laurent
261 schema:givenName Christophe
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01275745276.40
263 rdf:type schema:Person
264 sg:person.01347655027.14 schema:affiliation grid-institutes:grid.14925.3b
265 schema:familyName De Baere
266 schema:givenName Thierry
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01347655027.14
268 rdf:type schema:Person
269 sg:person.0576763251.36 schema:affiliation grid-institutes:grid.413133.7
270 schema:familyName Ulusakarya
271 schema:givenName Ayhan
272 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0576763251.36
273 rdf:type schema:Person
274 sg:person.0734163345.11 schema:affiliation grid-institutes:grid.14925.3b
275 schema:familyName Gelli
276 schema:givenName Maximiliano
277 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0734163345.11
278 rdf:type schema:Person
279 sg:person.07474010031.50 schema:affiliation grid-institutes:None
280 schema:familyName Pezzella
281 schema:givenName Veronica
282 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07474010031.50
283 rdf:type schema:Person
284 sg:person.07565600260.23 schema:affiliation grid-institutes:grid.418076.c
285 schema:familyName Audemar
286 schema:givenName Franck
287 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07565600260.23
288 rdf:type schema:Person
289 sg:person.0771070144.24 schema:affiliation grid-institutes:grid.8515.9
290 schema:familyName Dromain
291 schema:givenName Clarisse
292 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771070144.24
293 rdf:type schema:Person
294 sg:pub.10.1007/s00270-010-9996-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033215339
295 https://doi.org/10.1007/s00270-010-9996-6
296 rdf:type schema:CreativeWork
297 sg:pub.10.1038/sj.bjc.6603033 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051210499
298 https://doi.org/10.1038/sj.bjc.6603033
299 rdf:type schema:CreativeWork
300 sg:pub.10.1245/s10434-007-9581-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021729392
301 https://doi.org/10.1245/s10434-007-9581-7
302 rdf:type schema:CreativeWork
303 grid-institutes:None schema:alternateName Department of digestive surgery, CHP Saint Grégoire, Saint-Grégoire, France
304 R&D Unicancer, Paris, France
305 schema:name Department of digestive surgery, CHP Saint Grégoire, Saint-Grégoire, France
306 R&D Unicancer, Paris, France
307 rdf:type schema:Organization
308 grid-institutes:grid.14925.3b schema:alternateName Department of Medical Oncology, Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif Cedex, France
309 Department of Surgical Oncology, Gustave Roussy, Villejuif, France
310 Department of interventional radiology, Gustave Roussy, Villejuif, France
311 schema:name Department of Medical Oncology, Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif Cedex, France
312 Department of Surgical Oncology, Gustave Roussy, Villejuif, France
313 Department of interventional radiology, Gustave Roussy, Villejuif, France
314 rdf:type schema:Organization
315 grid-institutes:grid.411439.a schema:alternateName Department of radiology, CHU Pitié Salpétrière, Paris, France
316 schema:name Department of radiology, CHU Pitié Salpétrière, Paris, France
317 rdf:type schema:Organization
318 grid-institutes:grid.413133.7 schema:alternateName Department of medical oncology, Hôpital Paul Brousse, Villejuif, France
319 schema:name Department of medical oncology, Hôpital Paul Brousse, Villejuif, France
320 rdf:type schema:Organization
321 grid-institutes:grid.413328.f schema:alternateName Department of Surgical Oncology, Hôpital Saint Louis, Paris, France
322 schema:name Department of Surgical Oncology, Hôpital Saint Louis, Paris, France
323 rdf:type schema:Organization
324 grid-institutes:grid.414093.b schema:alternateName Department of digestive oncology, Hôpital Européen Georges-Pompidou, Sorbonne Paris Cite/Paris Descartes University, Paris, France
325 schema:name Department of digestive oncology, Hôpital Européen Georges-Pompidou, Sorbonne Paris Cite/Paris Descartes University, Paris, France
326 rdf:type schema:Organization
327 grid-institutes:grid.417988.b schema:alternateName Department of medical oncology, Centre Eugène-Marquis, Rennes, France
328 schema:name Department of medical oncology, Centre Eugène-Marquis, Rennes, France
329 rdf:type schema:Organization
330 grid-institutes:grid.418076.c schema:alternateName Department of hepatogastroenterology, Centre hospitalier Côte Basque, Bayonne, France
331 schema:name Department of hepatogastroenterology, Centre hospitalier Côte Basque, Bayonne, France
332 rdf:type schema:Organization
333 grid-institutes:grid.418191.4 schema:alternateName Department of medical oncology, Institut de Cancerologie de l’Ouest, Angers, France
334 schema:name Department of medical oncology, Institut de Cancerologie de l’Ouest, Angers, France
335 rdf:type schema:Organization
336 grid-institutes:grid.42399.35 schema:alternateName Department of hepatogastroenterology, Hôpital Haut Levêque, Pessac, France
337 schema:name Department of hepatogastroenterology, Hôpital Haut Levêque, Pessac, France
338 rdf:type schema:Organization
339 grid-institutes:grid.463845.8 schema:alternateName Centre for Research in Epidemiology and Population Health (team 2), INSERM U1018, Paris-Saclay University, Villejuif, France
340 schema:name Centre for Research in Epidemiology and Population Health (team 2), INSERM U1018, Paris-Saclay University, Villejuif, France
341 Department of statistics and epidemiology, Villejuif, France
342 rdf:type schema:Organization
343 grid-institutes:grid.8515.9 schema:alternateName Department of radiology, Centre Hospitalier et Universitaire Vaudois, Lausanne, Switzerland
344 schema:name Department of radiology, Centre Hospitalier et Universitaire Vaudois, Lausanne, Switzerland
345 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...